Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Caligor Rx Managing Director Tammy Bishop Elected to Board of Directors for DA4S

Published: Wednesday, May 22, 2013
Last Updated: Wednesday, May 22, 2013
Bookmark and Share
Diversity Alliance for Science (DA4S) is a national organization that fosters supplier diversity within the life sciences industry.

“It is a privilege to join the board of DA4S, and I look forward to contributing my knowledge and experience to help the organization achieve its strategic objectives,” said Bishop, whose term on the 16-member board runs through May 2017. “DA4S plays a vital role in championing the benefits of diversity within the life sciences community. I am eager to share the organization’s mission with leading life sciences companies across New England.”

“As the managing director of Caligor Rx, Tammy has demonstrated the strong, energetic and visionary leadership that supports DA4S’s mission to broaden supplier diversity across the entire life sciences community, including businesses and academic and government institutions,” said DA4S President Sylvester Wilkins. “Tammy ‘s more than 20 years of pharma industry experience and her unique entrepreneurial skills make her especially well suited to serve our board.”

Prior to joining Caligor Rx in 2010, Bishop worked in senior-level business development positions at Pharmarama and IDIS Pharmaceuticals. In addition, she served in senior corporate communications positions at OXiGENE, Gemini Genomics and Indevus Pharmaceuticals. In 2011, she was selected as a protégé for the DA4S Mentor Program and was instrumental in shepherding Caligor Rx’s national certification as a Woman-owned Business by the Women’s Business Enterprise National Council.

Bishop is a member of the Drug Information Association, Healthcare Distribution Management Association, Healthcare Women’s Business Association and Institute for Supply Chain Management. She received a Master’s Degree in Business Administration from the Simmons College School of Management.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
New Way of Displaying 3D Molecular Structures
Metal-organic frameworks provide a new platform for solving the structure of hard-to-study samples.
Agent Blocks Pain Without Morphine's Side Effects
Scientists have synthesised a molecule with specific pain-relief properties and has shown its efficacy in mice.
Cutting the Cost of Drug-Building Chemicals
EPFL scientists have developed a method to produce aryl-containing amines in a cheap and easily scalable way.
How Cloud Connectivity Can Combat the Reproducibility Crisis
This infographic explains the reproducibility crisis, and how cloud connectivity can help overcome this problem.
Accessing Metabolic Information with Mass Spec
Scientists at the Helmholtz Zentrum München have developed a new mass spectrometry imaging method which, for the first time, makes it possible to analyze hundreds of metabolites in fixed tissue samples.
Simplifying Gene Testing Access for Ovarian Cancer Patients
Simplifying access to gene testing for women with ovarian cancer improves treatment choices and could save lives.
New Protein Model Could Accelerate Drug Development
Stony Brook-led international research team creates ultra-fast approach to model protein interactions.
New Method Opens Door to Development of Many New Medicines
Findings from TSRI reveal human proteins are better drug targets than previously thought.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Angina Drug Could Inform A New Strategy To Fight Cryptococcosis
A drug, more commonly used in the treatment of angina, could be the focus of a new strategy in fighting the fatal fungal infection cryptococcosis.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!